Literature DB >> 23536324

2012 consensus document of the Italian Society of Hypertension (SIIA): strategies to improve blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy.

Massimo Volpe1, Enrico Agabiti Rosei, Ettore Ambrosioni, Santina Cottone, Cesare Cuspidi, Claudio Borghi, Nicola De Luca, Francesco Fallo, Claudio Ferri, Alberto Morganti, Maria Lorenza Muiesan, Riccardo Sarzani, Leonardo Sechi, Agostino Virdis, Giuliano Tocci, Bruno Trimarco, Alessandro Filippi, Giuseppe Mancia.   

Abstract

Observational clinical studies have demonstrated that only 30-40% of patients with arterial hypertension achieve the recommended blood pressure goals (below 140/90 mmHg). In contrast, interventional trials consistently showed that it is possible to achieve effective blood pressure targets in about 70% of treated hypertensive patients with different cardiovascular risk profiles, especially through the use of rational, effective and well tolerated combination therapies. In order to bridge the gap between current and desired blood pressure control and to achieve more effective prevention of cardiovascular diseases, the Italian Society of Hypertension (SIIA) has developed an interventional strategy aimed at reaching nearly 70% of treated controlled hypertensive patients by 2015. This ambitious goal can be realistically achieved by a more rational use of modern tools and supports, and also through the use of combination therapy in hypertension in daily clinical practice, especially if this approach can be simplified into a single pill (fixed combination therapy), which is a therapeutic option now also available in Italy. Since about 70-80% of treated hypertensive patients require a combination therapy based on at least two classes of drugs in order to achieve the recommended blood pressure goals, it is of key importance to implement this strategy in routine clinical practice. Amongst the various combination therapies currently available for hypertension treatment and control, the use of those strategies based on drugs that antagonize the renin-angiotensin system, such as angiotensin II type 1 receptor antagonists (angiotensin receptor blockers) and ACE inhibitors, in combination with diuretics and/or calcium channel blockers, has been shown to significantly reduce the risk of major cardiovascular events and to improve patient compliance to treatment, resulting in a greater antihypertensive efficacy and better tolerability compared with monotherapy. The present document of the Italian Society of Arterial Hypertension (SIIA) aims to gather the main indications for the implementation of combination therapy in the treatment of hypertension, in order to improve blood pressure control in Italy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23536324     DOI: 10.1007/s40292-013-0007-2

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  35 in total

1.  Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

Authors:  L Liu; J G Wang; L Gong; G Liu; J A Staessen
Journal:  J Hypertens       Date:  1998-12       Impact factor: 4.844

2.  Influence of carvedilol on blood glucose and glycohaemoglobin A1 in non-insulin-dependent diabetics.

Authors:  B Ehmer; R van der Does; J Rudorf
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

4.  Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial.

Authors:  Jan Václavík; Richard Sedlák; Martin Plachy; Karel Navrátil; Jirí Plásek; Jirí Jarkovsky; Tomás Václavík; Roman Husár; Eva Kociánová; Milos Táborsky
Journal:  Hypertension       Date:  2011-05-02       Impact factor: 10.190

5.  The effects of bisoprolol, a selective beta1-blocker, on glucose metabolism by long-term administration in essential hypertension.

Authors:  A Owada; S Suda; T Hata; S Miyake
Journal:  Clin Exp Hypertens       Date:  2001-05       Impact factor: 1.749

6.  Effectiveness of nebivolol and hydrochlorothiazide association on blood pressure, glucose, and lipid metabolism in hypertensive patients.

Authors:  Giuseppe Marazzi; Maurizio Volterrani; Giuseppe Caminiti; Luigi Iaia; Luca Cacciotti; Rosalba Massaro; Barbara Sposato; Cristiana Vitale; Giuseppe Mercuro; Giuseppe Rosano
Journal:  Adv Ther       Date:  2010-08-05       Impact factor: 3.845

7.  Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.

Authors:  Hans-Henrik Parving; Barry M Brenner; John J V McMurray; Dick de Zeeuw; Steven M Haffner; Scott D Solomon; Nish Chaturvedi; Mathieu Ghadanfar; Nicole Weissbach; Zhihua Xiang; Juergen Armbrecht; Marc A Pfeffer
Journal:  Nephrol Dial Transplant       Date:  2009-01-14       Impact factor: 5.992

8.  Blood pressure control in Italy: results of recent surveys on hypertension.

Authors:  Massimo Volpe; Giuliano Tocci; Bruno Trimarco; Enrico Agabiti Rosei; Claudio Borghi; Ettore Ambrosioni; Alessandro Menotti; Alberto Zanchetti; Giuseppe Mancia
Journal:  J Hypertens       Date:  2007-07       Impact factor: 4.844

9.  Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system.

Authors:  F Turnbull; B Neal; M Pfeffer; J Kostis; C Algert; M Woodward; J Chalmers; A Zanchetti; S MacMahon
Journal:  J Hypertens       Date:  2007-05       Impact factor: 4.844

Review 10.  Blood pressure control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension.

Authors:  Giuliano Tocci; Enrico Agabiti Rosei; Ettore Ambrosioni; Claudio Borghi; Claudio Ferri; Andrea Ferrucci; Giuseppe Mancia; Alberto Morganti; Roberto Pontremoli; Bruno Trimarco; Alberto Zanchetti; Massimo Volpe
Journal:  J Hypertens       Date:  2012-06       Impact factor: 4.844

View more
  32 in total

Review 1.  The benefit of angiotensin AT1 receptor blockers for early treatment of hypertensive patients.

Authors:  Bruno Trimarco; Ciro Santoro; Marco Pepe; Maurizio Galderisi
Journal:  Intern Emerg Med       Date:  2017-08-02       Impact factor: 3.397

2.  Use of Fixed Combination Therapies to Improve Blood Pressure Control in the Clinical Management of Hypertension: A Key Opportunity.

Authors:  Giuliano Tocci; Agostino Virdis
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-09-10

3.  Association Between Lifestyle and Systemic Arterial Hypertension in Young Adults: A National, Survey-Based, Cross-Sectional Study.

Authors:  Rosa Maria Bruno; Giacomo Pucci; Martina Rosticci; Laura Guarino; Chiara Guglielmo; Claudia Agabiti Rosei; Silvia Monticone; Alessandra Giavarini; Chiara Lonati; Camilla Torlasco; Massimiliano Fedecostante; Maria Virginia Manzi; Francesca Pezzutto; Marina Di Pilla; Nathan Artom; Allegra Battistoni; Giulia Pignatelli; Viola Sanga; Martino Francesco Pengo
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-02-24

4.  Different strategies from monotherapies to dual or triple fixed dose combination therapies to achieve blood pressure goals: a summary of a satellite symposium from the European Society of Hypertension, June 13-16, 2014 Athens, Greece. Introduction.

Authors:  Josep Redon
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-07

5.  Lack of blood pressure control in Italy: room for improvement?

Authors:  M Lorenza Muiesan
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-12-03

6.  National Cross-Sectional Survey on Blood Pressure: A Gateway to a Better Appraisal of Hypertension in the Young.

Authors:  Massimo Volpe; Claudio Borghi
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-04-27

7.  Clinical management of renovascular hypertension: practical recommendations from the Italian Society of Hypertension (SIIA).

Authors:  Chiara Lonati; Alberto Morganti
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-09-11

8.  Echocardiography in hypertension: practical recommendations from the Italian Society of Hypertension (SIIA).

Authors:  Cesare Cuspidi; Nicola De Luca; Maria Lorenza Muiesan
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-09-17

9.  Clinical management of primary aldosteronism: 2013 Practical Recommendations of the Italian Society of Hypertension (SIIA).

Authors:  Gian Paolo Rossi; Anna Dalla Cà
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-01-25

Review 10.  Italian Society of Arterial Hypertension (SIIA) Position Paper on the Role of Renal Denervation in the Management of the Difficult-to-Treat Hypertensive Patient.

Authors:  Rosa Maria Bruno; Stefano Taddei; Claudio Borghi; Furio Colivicchi; Giovambattista Desideri; Guido Grassi; Alberto Mazza; Maria Lorenza Muiesan; Gianfranco Parati; Roberto Pontremoli; Bruno Trimarco; Massimo Volpe; Claudio Ferri
Journal:  High Blood Press Cardiovasc Prev       Date:  2020-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.